These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30036559)

  • 41. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
    Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
    Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
    Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
    Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
    Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
    J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
    Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
    Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis.
    Sayed IM; Verhoye L; Montpellier C; Abravanel F; Izopet J; Cocquerel L; Meuleman P
    J Infect Dis; 2019 Jul; 220(5):811-819. PubMed ID: 31001628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Qu C; Xu L; Yin Y; Peppelenbosch MP; Pan Q; Wang W
    Arch Virol; 2017 Oct; 162(10):2989-2996. PubMed ID: 28623406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
    Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
    Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
    Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
    Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
    Blum L; Geisslinger G; Parnham MJ; Grünweller A; Schiffmann S
    J Cell Mol Med; 2020 Jun; 24(12):6988-6999. PubMed ID: 32374474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of hepatitis E virus replication by zinc-finger antiviral Protein synergizes with IFN-β.
    Yu W; Ji H; Long F; Chen S; He Q; Xia Y; Cong C; Yang C; Wei D; Huang F
    J Viral Hepat; 2021 Aug; 28(8):1219-1229. PubMed ID: 33894039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin.
    Primadharsini PP; Nagashima S; Takahashi M; Murata K; Okamoto H
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
    Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection.
    Kupke P; Adenugba A; Schemmerer M; Bitterer F; Schlitt HJ; Geissler EK; Wenzel JJ; Werner JM
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral Candidates for Treating Hepatitis E Virus Infection.
    Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Small Animal Models of Hepatitis E Virus Infection.
    Li TC; Wakita T
    Cold Spring Harb Perspect Med; 2019 Aug; 9(8):. PubMed ID: 29735581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis E virus infection.
    Kamar N; Izopet J; Pavio N; Aggarwal R; Labrique A; Wedemeyer H; Dalton HR
    Nat Rev Dis Primers; 2017 Nov; 3():17086. PubMed ID: 29154369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
    Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
    J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.